Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-κB Signaling Pathway

Figure 5

JPYF II increased the activities of CAT and GSH-Px, as well as decreased the level of MDA in lung tissues caused by LPS and CS exposure. (a) CAT, (b) GSH-Px, and (c) MDA. Control: saline-treated mice; model: LPS and CS-exposed mice; low: JPYF II (0.75 g/kg/d) + LPS and CS-exposed mice; middle: JPYF II (1.5 g/kg/d) + LPS and CS-exposed mice; high: JPYF II (3 g/kg/d) + LPS and CS-exposed mice; dexamethasone: dexamethasone (2 mg/kg/d) + LPS and CS-exposed mice. Values are presented as means ± SD. ^###P < 0.001 compared with control mice; < 0.05, < 0.01, and < 0.001 compared with LPS and CS-exposed mice.

(a)

(b)

(c)